EUVIMEDEUVIMED entdecken
Crossref

Subcutaneous methotrexate for treating rheumatoid arthritis in Portugal: a cost-utility analysis versus current practice

ARP Rheumatology · 2026

DOI: 10.63032/clnt5799 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ARP Rheumatology, 2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Subcutaneous methotrexate for treating rheumatoid arthritis in Portugal: a cost-utility analysis versus current practice. ARP Rheumatology. https://doi.org/10.63032/clnt5799

Vancouver

Subcutaneous methotrexate for treating rheumatoid arthritis in Portugal: a cost-utility analysis versus current practice. ARP Rheumatology. 2026. doi:10.63032/clnt5799

BibTeX
@article{euvimed2026,
  title = {Subcutaneous methotrexate for treating rheumatoid arthritis in Portugal: a cost-utility analysis versus current practice},
  journal = {ARP Rheumatology},
  year = {2026},
  doi = {10.63032/clnt5799}
}
Kostenlos starten →